Lawrence F. Eichenfield, MD, FAAD
University of California San Diego and Rady Children's Hospital
BIOGRAPHY
Dr. Lawrence Eichenfield is a Distinguished Professor of Dermatology and Pediatrics, Vice Chair of the Department of Dermatology and Chief of Pediatric and Adolescent Dermatology at University of California San Diego School of Medicine and Rady Children’s Hospital San Diego. He received his MD from Mt. Sinai School of Medicine, completed his Pediatrics residency and chief residency at Children’s Hospital of Philadelphia and dermatology residency at the University of Pennsylvania. Dr. Eichenfield’s clinical interests include atopic dermatitis and other inflammatory skin diseases (including psoriasis, acne, vitiligo and alopecia), rare skin disorders, neonatal dermatology and laser surgery. He has authored more than 550 journal articles and has served as the senior editor of Neonatal and Infant Dermatology and The Eczemas. Dr. Eichenfield has served in multiple leadership positions including being a co-founder and Chair of the Pediatric Dermatology Research Alliance (PeDRA), past president of the Society for Pediatric Dermatology, a founding board member and President of the American Acne and Rosacea Society, Board Member of the AAD, and serves as Director of the Rady/UCSD Eczema and Inflammatory Skin Disease Center and President-elect of the International Eczema Council.
SESSIONS
DISCLOSURES
Abbvie – Investigator(Grants/Research Funding); Abeona Therapeutics – Consultant (1099 relationship)(Honoraria); Acrotech Biopharma Inc – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Fees); Bristol-Myers Squibb – Consultant(Honoraria); Castle Biosciences – Consultant (1099 relationship)(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Chiesi Farmaceutici – Consultant (1099 relationship)(Honoraria); Dermata Therapeutics – Consultant (1099 relationship)(Stock); Dermavant Sciences, Inc. – Consultant(Honoraria); Eli Lilly – Consultant(Honoraria), Investigator(Grants/Research Funding); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Forte Biosciences – Consultant (1099 relationship)(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); Krystal Biotech, Inc – Consultant(Honoraria); Kymera Therapeutics – Consultant (1099 relationship)(Honoraria); LEO Pharma, US – Consultant(Honoraria), Investigator(Fees); Lilly ICOS LLC – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Honoraria); Organon – Consultant (1099 relationship)(Honoraria); Ortho Dermatologics – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Fees); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Target RWE – Investigator(Grants/Research Funding); TopMD – Consultant(Stock Options); TRex Bio – Consultant (1099 relationship)(Honoraria); TrialSpark, Inc. – Consultant(Honoraria); UCB – Consultant(Honoraria); Verrica Pharmaceuticals Inc – Board of Directors(Fees), Board of Directors(Stock Options); Wiley-Blackwell – Other(Honoraria);